Literature DB >> 24497464

Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis.

Adoracion Martinez-Palacian1, Sandip M Kanse, Ralf Weiskirchen.   

Abstract

Factor VII activating protease (FSAP) is a multifunctional serine protease that is mainly synthesized and secreted by hepatocytes. This enzyme is highly evolutionarily conserved and contains three epidermal growth factor like domains, a kringle domain and a trypsin-like serine protease signature at its C-terminus. Animal experimentation and clinical findings indicate that FSAP influences a range of inflammatory fibroproliferative diseases. In particular, recent work demonstrated that FSAP is anti-fibrotic and influences liver fibrosis progression. The relative high physiological concentration, occurrence of gene variants affecting the proteolytic activity of FSAP and eclectic substrate specificity should in principal presuppose this protease to be frequently found in studies in which quantitative proteomics is performed. However, presently there are only a few studies available that have identified FSAP in applications using 2D gels, MS or other proteomic-associated techniques. We summarize here the actual knowledge about FSAP functions in initiation and progression of hepatic fibrosis and comment on proteome studies in which altered expression or activity of FSAP was reported.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  FSAP; HABP2; Inflammation; Liver fibrosis; Remodelling

Mesh:

Substances:

Year:  2014        PMID: 24497464     DOI: 10.1002/prca.201300078

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  3 in total

1.  Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.

Authors:  Silke Leiting; Sebastian Seidl; Adoracion Martinez-Palacian; Lars Muhl; Sandip M Kanse
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

2.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

3.  Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis.

Authors:  Donggyu Nam; Myung Rae Park; Hyunah Lee; Sung Chul Bae; Daniela Gerovska; Marcos J Araúzo-Bravo; Holm Zaehres; Hans R Schöler; Jeong Beom Kim
Journal:  Cells       Date:  2022-07-19       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.